Last reviewed · How we verify
NCT07199660
Reactions to Social Media Warning Labels Among Teens and Young Adults
NA trial testing Human-developed negative body image warning in Screen Time Exposure in 1,012 participants. Completed in 16 December 2025.
16 December 2025
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 1,012 |
| Start date | 2 December 2025 |
| Primary completion | 16 December 2025 |
| Estimated completion | 16 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Human-developed negative body image warning
- Voluntary warning
- Human-developed depression and anxiety warning
- Human-developed addiction warning
- Human-developed sleep warning
- Human-developed mental health harms to young people warning
- Human-developed warning that social media has not been proven safe
- Control message
- California's proposed social media warning
- Artificial-intelligence-developed depression and anxiety warning
- Artificial-intelligence-developed negative body image warning
- Artificial-intelligence-developed addiction warning
- Artificial-intelligence-developed sleep warning
- Artificial-intelligence-developed mental health harms to young people warning
- Artificial-intelligence-developed warning that social media has not been proven safe
Conditions studied
- Screen Time Exposure — all drugs for Screen Time Exposure →
Sponsor
Stanford University
Who can join
Adults 13 to 29, any sex, with Screen Time Exposure. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective of this study is to evaluate whether social media warnings are perceived as more effective than control labels among teens and young adults, and to identify the most promising topics for social media warnings for these age groups. A secondary objective is to compare perceived message effectiveness of warnings refined using artificial intelligence (AI) vs. those not refined using AI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07199660
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Screen Time Exposure
Currently open trials in the same condition.
- NCT07004036 — The Effects Of Occupation-Based Self-Regulation Program On Sensory Processing, Executive Functions and Occupational Perf · NA · active not recruiting
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07199660 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 16 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07199660.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing